Posted by Michael Wonder on 04 Sep 2022
Australia among world's best in treating debilitating and often fatal muscle disorder
4 September - Australia has become one of the first countries in the world to fund a new, next-generation treatment for people with a potentially fatal muscle disorder known as Pompe disease.
The Federal Government will add Nexviazyme (avalglucosidase alfa) to the Life Saving Drugs Program from September 1 for the treatment of Australians one year of age and older with Pompe disease, a progressive and debilitating muscle disorder that impairs a person’s ability to move and breathe.
